Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience

Surgery. 2000 Apr;127(4):395-404. doi: 10.1067/msy.2000.104250.

Abstract

Background: Hilar resection, especially in combination with liver resection, results in substantial morbidity and mortality, which clearly influences the overall outcome. In the present study, patients who underwent resection of a proximal bile duct tumor were analyzed with the aim of identifying risk factors for morbidity and mortality.

Methods: Between 1983 and 1998, 112 consecutive patients underwent a local resection, which in 32 patients was combined with a hemihepatectomy (11 extended resections). Eighty-four percent of the patients underwent preoperative (endoscopic) drainage. For evaluation of different treatment strategies during the study, the period was divided in three 5-year intervals.

Results: Postoperative complications occurred in 65% of the patients. The overall hospital mortality was 15% for local resections and 25% for hemi-hepatectomies. There was a significantly lower morbidity and no mortality after hilar resection during the last 5 years. A higher Bismuth classification showed significant correlation with postoperative morbidity. Extended liver resections and vascular resections and a preoperative albumin level below 35 g/L were found to be significant predictors of increased mortality in univariate analysis.

Conclusions: The overall morbidity and mortality rate in this series is higher than most recently published series. More (extended) liver resections resulted in an increased rate of microscopic tumor-free resections, at the cost of higher hospital morbidity and mortality. Improved preoperative work-ups will result in a selection of patients who might benefit from these extensive resections.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Bile Duct Neoplasms / mortality
  • Bile Duct Neoplasms / surgery*
  • Bile Ducts, Intrahepatic*
  • Cholangiocarcinoma / mortality
  • Cholangiocarcinoma / surgery*
  • Female
  • Follow-Up Studies
  • Hepatectomy / adverse effects*
  • Hepatectomy / mortality
  • Humans
  • Male
  • Middle Aged
  • Morbidity
  • Retrospective Studies
  • Risk Factors
  • Serum Albumin / analysis
  • Time Factors

Substances

  • Serum Albumin